Chemed Corporation $CHE is DRH Investments Inc.’s 8th Largest Position

DRH Investments Inc. reduced its stake in Chemed Corporation (NYSE:CHEFree Report) by 8.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 19,155 shares of the company’s stock after selling 1,820 shares during the quarter. Chemed makes up 7.5% of DRH Investments Inc.’s investment portfolio, making the stock its 8th largest holding. DRH Investments Inc. owned 0.14% of Chemed worth $8,196,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Northwestern Mutual Wealth Management Co. raised its position in Chemed by 2,444,879.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock valued at $2,374,667,000 after buying an additional 5,549,876 shares during the last quarter. JPMorgan Chase & Co. grew its stake in Chemed by 4.4% in the 4th quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock valued at $223,301,000 after purchasing an additional 21,932 shares during the period. William Blair Investment Management LLC grew its stake in Chemed by 13.6% in the 3rd quarter. William Blair Investment Management LLC now owns 385,124 shares of the company’s stock valued at $172,435,000 after purchasing an additional 46,038 shares during the period. TD Asset Management Inc grew its stake in Chemed by 7.5% in the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after purchasing an additional 22,715 shares during the period. Finally, Epoch Investment Partners Inc. grew its stake in Chemed by 4.9% in the 4th quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock valued at $137,945,000 after purchasing an additional 15,133 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on CHE shares. Royal Bank Of Canada upped their price objective on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Oppenheimer reduced their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, February 27th. Finally, Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Two investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $501.50.

Get Our Latest Report on CHE

Chemed Stock Down 0.4%

CHE stock opened at $419.07 on Friday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The company has a market capitalization of $5.56 billion, a price-to-earnings ratio of 22.84, a PEG ratio of 1.57 and a beta of 0.54. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $562.77. The stock has a fifty day moving average of $415.27 and a 200-day moving average of $424.51.

Chemed (NYSE:CHEGet Free Report) last posted its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping the consensus estimate of $5.30 by $0.35. The company had revenue of $657.51 million during the quarter, compared to the consensus estimate of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, equities research analysts predict that Chemed Corporation will post 22.3 earnings per share for the current year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th will be paid a dividend of $0.60 per share. The ex-dividend date is Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s dividend payout ratio is presently 13.08%.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director owned 4,578 shares of the company’s stock, valued at $2,047,876.74. The trade was a 22.73% decrease in their position. The SEC filing for this sale provides additional information. 3.33% of the stock is currently owned by corporate insiders.

Chemed Company Profile

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Recommended Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.